Subtopic Deep Dive

HAX1 Deficiency
Research Guide

Q: What defines HAX1 deficiency?

Autosomal recessive severe congenital neutropenia from HAX1 mutations disrupting myeloid apoptosis regulation (Klein et al., 2006).

Q: What are main diagnostic methods?

Genetic sequencing of HAX1 alongside neutrophil counts <0.5 G/l; classified in IUIS PID reports (Picard et al., 2017; Bousfiha et al., 2017).

Q: What are key papers?

Klein et al. (2006, Nature Genetics, 499 citations) discovered HAX1 link; Donadieu et al. (2011) details management; Geha et al. (2007) provides PID context.

Q: What open problems exist?

Ethnic mutation variability, precise mitochondrial mechanisms, and long-term post-HSCT risks remain unresolved (Fadeel and Grzybowska, 2009; Donadieu et al., 2011).

What is HAX1 Deficiency?

HAX1 deficiency is an autosomal recessive genetic disorder caused by mutations in the HAX1 gene, leading to severe congenital neutropenia (Kostmann disease) and impaired neutrophil production due to apoptosis defects in myeloid cells.

First identified in 2006, HAX1 mutations disrupt mitochondrial anti-apoptotic functions, causing profound neutropenia with absolute neutrophil counts below 0.5 G/l (Klein et al., 2006, 499 citations). The condition predominates in certain ethnic groups and associates with increased infection susceptibility. Over 20 papers in provided lists classify it within primary immunodeficiencies and congenital neutropenias.

Curated Papers

Key Challenges

Why It Matters

HAX1 deficiency research enables precise genetic diagnosis and screening in high-prevalence populations, improving early hematopoietic stem cell transplantation outcomes (Klein et al., 2006). Studies clarify neutropenia pathogenesis, informing therapies for related myeloid disorders (Donadieu et al., 2011). Classifications by IUIS committees guide clinical management across inborn errors of immunity (Picard et al., 2017; Bousfiha et al., 2017).

Key Research Challenges

Mutation Spectrum Variability

HAX1 mutations vary by ethnicity, complicating universal genetic screening protocols (Klein et al., 2006). Identifying novel variants requires sequencing across diverse cohorts (Donadieu et al., 2011). Functional validation of pathogenicity remains inconsistent.

Apoptosis Mechanism Elucidation

Exact role of HAX1 in mitochondrial stability and neutrophil survival needs deeper study (Fadeel and Grzybowska, 2009). Links to broader anti-apoptotic pathways in hematopoiesis are underexplored. In vivo models lag behind human data (Klein et al., 2006).

Long-term Treatment Monitoring

Post-transplant outcomes and malignancy risks in HAX1-deficient patients demand longitudinal studies (Donadieu et al., 2011). Differentiating from other neutropenias like ELANE or WASp-related forms challenges management (Geha et al., 2007).

Essential Papers

International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity

Capucine Pïcard, H. Bobby Gaspar, Waleed Al–Herz et al. · 2017 · Journal of Clinical Immunology · 774 citations

Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee

Raif S. Geha, Luigi D. Notarangelo, Jean‐Laurent Casanova et al. · 2007 · Journal of Allergy and Clinical Immunology · 559 citations

The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies

Aziz Bousfiha, Leïla Jeddane, Capucine Pïcard et al. · 2017 · Journal of Clinical Immunology · 511 citations

Since the 1990s, the International Union of Immunological Societies (IUIS) PID expert committee (EC), now called Inborn Errors of Immunity Committee, has published every other year a classification...

HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)

Christoph Klein, Magda Grudzien, Giridharan Appaswamy et al. · 2006 · Nature Genetics · 499 citations

Congenital neutropenia: diagnosis, molecular bases and patient management

Jean Donadieu, Odile Fenneteau, Blandine Beaupain et al. · 2011 · Orphanet Journal of Rare Diseases · 210 citations

The term congenital neutropenia encompasses a family of neutropenic disorders, both permanent and intermittent, severe (<0.5 G/l) or mild (between 0.5-1.5 G/l), which may also affect other organ sy...

Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia

Dale Moulding, Michael P. Blundell, David G. Spiller et al. · 2007 · The Journal of Experimental Medicine · 158 citations

Specific mutations in the human gene encoding the Wiskott-Aldrich syndrome protein (WASp) that compromise normal auto-inhibition of WASp result in unregulated activation of the actin-related protei...

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options

Charlotte M. Niemeyer, Christian P. Kratz · 2008 · British Journal of Haematology · 144 citations

Summary Myelodysplastic syndromes (MDS) and the mixed myelodysplastic/myeloproliferative disorder juvenile myelomonocytic leukaemia (JMML) are rare haematopoietic stem cell diseases in children. Wh...

Reading Guide

Foundational Papers

Start with Klein et al. (2006) for HAX1 discovery in Kostmann disease, then Geha et al. (2007) for PID classification context, followed by Donadieu et al. (2011) for diagnostics.

Recent Advances

Picard et al. (2017) and Bousfiha et al. (2017) IUIS updates integrate HAX1 into immunity error catalogs; Fadeel and Grzybowska (2009) explores multifunctional roles.

Core Methods

Genetic sequencing, flow cytometry for neutropenia, mitochondrial apoptosis assays; classifications via IUIS phenotypic tables (Klein et al., 2006; Picard et al., 2017).

How PapersFlow Helps You Research HAX1 Deficiency

Discover & Search

Research Agent uses searchPapers and citationGraph on 'HAX1 neutropenia' to map 499-citation Klein et al. (2006) as central node, revealing IUIS classifications (Picard et al., 2017). exaSearch uncovers ethnic prevalence patterns; findSimilarPapers links to Donadieu et al. (2011) for management insights.

Analyze & Verify

Analysis Agent applies readPaperContent to Klein et al. (2006) for mutation details, then verifyResponse with CoVe to cross-check against Picard et al. (2017). runPythonAnalysis parses neutropenia severity stats from Donadieu et al. (2011) abstracts using pandas for incidence rates; GRADE grading scores evidence strength for autosomal recessive inheritance.

Synthesize & Write

Synthesis Agent detects gaps in HAX1 therapy trials via contradiction flagging across IUIS reports, generating exportMermaid diagrams of mutation-pathogenesis pathways. Writing Agent uses latexEditText and latexSyncCitations to draft review sections citing Klein (2006), with latexCompile for publication-ready output.

Use Cases

"Analyze HAX1 mutation frequencies in congenital neutropenia cohorts using Python."

Research Agent → searchPapers('HAX1 mutations neutropenia') → Analysis Agent → readPaperContent(Donadieu 2011) + runPythonAnalysis(pandas aggregation of ANC <0.5 G/l data) → CSV export of prevalence table.

"Write LaTeX review on HAX1 deficiency pathogenesis with citations."

Synthesis Agent → gap detection(Klein 2006 + Fadeel 2009) → Writing Agent → latexEditText('pathway description') → latexSyncCitations(IUIS papers) → latexCompile → PDF manuscript.

"Find code for modeling HAX1 apoptosis defects from related papers."

Research Agent → citationGraph(Klein 2006) → Code Discovery → paperExtractUrls → paperFindGithubRepo(WASp neutropenia models) → githubRepoInspect → Python scripts for actin-mitosis simulation.

Automated Workflows

Deep Research workflow scans 50+ OpenAlex papers on HAX1, chaining searchPapers → citationGraph → structured report with Klein (2006) as anchor. DeepScan applies 7-step analysis: readPaperContent(Donadieu 2011) → CoVe verification → GRADE on management evidence. Theorizer generates hypotheses on HAX1-ELANE interactions from IUIS classifications.

Try Doxa for HAX1 Deficiency Research

Frequently Asked Questions

What defines HAX1 deficiency?

Autosomal recessive severe congenital neutropenia from HAX1 mutations disrupting myeloid apoptosis regulation (Klein et al., 2006).

What are main diagnostic methods?

Genetic sequencing of HAX1 alongside neutrophil counts <0.5 G/l; classified in IUIS PID reports (Picard et al., 2017; Bousfiha et al., 2017).

What are key papers?

Klein et al. (2006, Nature Genetics, 499 citations) discovered HAX1 link; Donadieu et al. (2011) details management; Geha et al. (2007) provides PID context.

What open problems exist?

Ethnic mutation variability, precise mitochondrial mechanisms, and long-term post-HSCT risks remain unresolved (Fadeel and Grzybowska, 2009; Donadieu et al., 2011).